Background: A National human papilloma virus (HPV) Vaccination Programme for the
prevention of HPV infection and associated disease using the quadrivalent HPV vaccine …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Objective To examine factors associated with parents' uptake of human papillomavirus
(HPV) vaccines for their children. Design Systematic review and meta-analysis. Data …

Human papillomavirus (HPV) vaccination prevents cervical, head and neck, and anogenital
cancers. However, global HPV vaccine coverage falls short of global targets and has seen …

Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71
countries. Unfortunately, uptake has been impacted in some countries by reduced …

Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …

The past 10 years have seen remarkable progress in the global scale‐up of human
papillomavirus (HPV) vaccinations. Forty‐three low‐and lower‐middle‐income countries …

Despite being an effective cancer prevention strategy, human papillomavirus (HPV)
vaccination in Canada remain suboptimal. This study is the first to concurrently evaluate …

Vaccination to prevent human papillomavirus infections: From promise to practice | PLOS
Medicine Skip to main content Advertisement PLOS Medicine Browse Current Issue Journal …

Human papillomavirus (HPV) is the most common sexually transmitted disease in the world.
The aim of our study is to describe the differences in HPV‐vaccination coverage and …